Vol 47, No 2 (2016)
Prace poglądowe / Reviews
Published online: 2016-04-01

open access

Page views 211
Article views/downloads 949
Get Citation

Connect on Social Media

Connect on Social Media

Metformin: an old drug in new application

Anna Dmoszyńska1, Monika Podhorecka2, Krzysztof Giannopoulos34
DOI: 10.1016/j.achaem.2016.04.001
Acta Haematol Pol 2016;47(2):139-145.


Metformin is a biguanide derivative that was synthesized in the 20's of last century. The main mechanism of action is the ability to inhibit hepatic gluconeogenesis and trigger glucose uptake in skeletal muscles. Metformin is not only an antihyperglycaemic drug but also has protective effects on endothelium cells. In the last decade, many publications displayed that metformin can reduce risk of cancer in diabetic patients and demonstrated a protective effect against certain types of cancer. In this review article, we discuss known mechanisms of metformin anticancer action and its beneficial role as vascular protective and anticancer agent.

Article available in PDF format

View PDF (Polish) Download PDF file